Combination therapy of dyslipidemia

被引：9

作者：

Goldberg A.C. ^{[1
]}

机构：

[1] Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110

来源：

Current Treatment Options in Cardiovascular Medicine | 2007年 / 9卷 / 4期

关键词：

Statin; Simvastatin; Atorvastatin; Ezetimibe; Cholesteryl Ester Transfer Protein;

D O I：

10.1007/s11936-007-0020-7

中图分类号：

学科分类号：

摘要：

Clinical trials have demonstrated the benefit of low-density lipoprotein (LDL) cholesterol reduction and, with less robust evidence, reduction of triglyceride levels and increased high-density lipoprotein (HDL) cholesterol in the prevention of atherosclerotic cardiovascular disease. Although the statins are the cornerstone of lipid-lowering therapy, they may not be adequate to accomplish all of the changes in lipid and lipoprotein levels called for in current guidelines. Combinations of one or more lipid-modifying drugs in addition to lifestyle changes are now part of clinical guidelines and are being used extensively in practice. Clinicians need to be familiar with the individual drugs and how they interact. There is also a need for outcome data with combination therapy, especially for statin-fibrate and statin-niacin combinations. Several clinical trials are underway and should provide further evidence for the benefit of combination therapy of dyslipidemia. New drug classes have the potential to provide additive effects with currently available medications to provide substantial LDL reduction and increased HDL level that may lead to a substantial reduction in the burden of atherosclerotic vascular disease. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：249 / 258

页数：9

共 46 条

[1]

Baigent C., Keech A., Kearney P.M., Et al., Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, pp. 1267-1278, (2005)

[2]

Cannon C.P., Braunwald E., McCabe C.H., Et al., Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, pp. 1495-1504, (2004)

[3]

LaRosa J.C., Grundy S.M., Waters D.D., Et al., Intensive lipid lowering with atorvastatin in patients with stable coronary disease, N Engl J Med, 352, pp. 1425-1435, (2005)

[4]

Taylor A.J., Sullenberger L.E., Lee H.J., Et al., Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins, Circulation, 110, pp. 3512-3517, (2004)

[5]

Whitney E.J., Krasuski R.A., Personius B.E., Et al., A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: Effects on progression of coronary heart disease and clinical events, Ann Intern Med, 142, pp. 95-104, (2005)

[6]

Grundy S.M., Cleeman J.I., Metz C.N., Et al., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation, 110, pp. 227-239, (2004)

[7]

Evaluation, and Treatment of High blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, pp. 2486-2497, (2001)

[8]

Pearson T.A., Laurora I., Chu H., Kafonek S., The Lipid Treatment Assessment Project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals, Arch Intern Med, 160, pp. 459-467, (2000)

[9]

Davidson M.H., Toth P.P., Combination therapy in the management of complex dyslipidemias, Curr Opin Lipidol, 15, pp. 423-431, (2004)

[10]

Smith S.C., Allen J., Blair S.N., Et al., AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update, Circulation, 113, pp. 2363-2372, (2006)

← 1 2 3 4 5 →